Globeflex Capital’s AngioDynamics ANGO Stock Holding History

Globeflex Capital’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Hold	104,155	–	–	0.17%	143
2026 Q1	$1.18M	Hold	104,155	–	–	0.18%	133
2025 Q4	$1.34M	Hold	104,155	–	–	0.2%	123
2025 Q3	$1.16M	Sell	104,155 -17,792	-15%	-$172K	0.18%	143
2025 Q2	$1.21M	Hold	121,947	–	–	0.1%	168
2025 Q1	$1.15M	Hold	121,947	–	–	0.11%	159
2024 Q4	$1.12M	Hold	121,947	–	–	0.09%	173
2024 Q3	$949K	Buy	+121,947	New	+$881K	0.09%	189
2021 Q3	–	Sell	-12,285	Closed	-$333K	–	459
2021 Q2	$333K	Buy	+12,285	New	+$300K	0.06%	339
2016 Q2	–	Sell	-26,822	Closed	-$330K	–	452
2016 Q1	$330K	Hold	26,822	–	–	0.09%	277
2015 Q4	$326K	Buy	26,822 +7,233	+37%	+$89.1K	0.09%	273
2015 Q3	$258K	Hold	19,589	–	–	0.06%	353
2015 Q2	$321K	Sell	19,589 -59,890	-75%	-$994K	0.06%	340
2015 Q1	$1.41M	Sell	79,479 -1	-0%	-$19	0.27%	128
2014 Q4	$1.51M	Buy	+79,480	New	+$1.35M	0.29%	106

Other funds holding ANGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.7M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

WCM

Weber Capital Management San Francisco, California $118M AUM

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Globeflex Capital's ANGO Position: Q2 2026 in Review

Globeflex Capital held its AngioDynamics (ANGO) position steady in Q2 2026 at 104,155 shares worth $1.36M. The position accounts for 0.17% of the portfolio, ranked #143.

Globeflex Capital first reported a position in ANGO in Q4 2014 and has held it in 15 quarters since. The position peaked at $1.51M in Q4 2014. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

Globeflex Capital held 104,155 shares of AngioDynamics worth $1.36M as of Q2 2026.
Globeflex Capital left its AngioDynamics share count unchanged in Q2 2026.
AngioDynamics made up 0.17% of Globeflex Capital's portfolio in Q2 2026, its #143 holding.
Globeflex Capital first reported a position in AngioDynamics in Q4 2014 and has held it in 15 quarters since.
Globeflex Capital's AngioDynamics position peaked at $1.51M in Q4 2014.
161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.